BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 7513917)

  • 1. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
    Halim S; Ramsingh AI
    Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
    Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
    Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.
    Foo DG; Alonso S; Phoon MC; Ramachandran NP; Chow VT; Poh CL
    Virus Res; 2007 Apr; 125(1):61-8. PubMed ID: 17222936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus.
    Muller S; Guichard G; Benkirane N; Brown F; Van Regenmortel MH; Briand JP
    Pept Res; 1995; 8(3):138-44. PubMed ID: 7670228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
    Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
    Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Coxsackie B virus IgM antibody in myocarditis patients by Mac ELISA.
    Zhu H; Zhang LB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):370-2. PubMed ID: 11471030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic sites of coxsackievirus A9.
    Pulli T; Lankinen H; Roivainen M; Hyypiä T
    Virology; 1998 Jan; 240(2):202-12. PubMed ID: 9454693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly.
    Cotmore SF; D'abramo AM; Ticknor CM; Tattersall P
    Virology; 1999 Feb; 254(1):169-81. PubMed ID: 9927584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
    Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
    Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
    Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coxsackie B virus infections in cardiology. Apropos of 66 cases].
    Wattré P; Leroy O; Dewilde A; Thery C
    Pathol Biol (Paris); 1987 Apr; 35(4):347-52. PubMed ID: 3035466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.